stay updated with our newsletter

Cannabidiol Offers Inflammatory Properties for Contact Dermatitis

This study is the first demonstration of the anti-inflammatory properties of Cannabidiol in an experimental model for allergic contact dermatitis (ACD). Published in the J. Pharmacology and Experimental Therapeutics, March 2018. Abstract / Phytocannabinoids modulate inflammatory responses by regulating the production of cytokines in several experimental models of inflammation. Cannabinoid type-2Read

CBD for Drug and Alcohol Recovery? Preclinical Study Shows Cannabidiol (CBD) May Be An Effective Solution

CBD for drug and alcohol recovery

Have you thought of prescribing CBD for drug and alcohol recovery? There is new evidence that the non-psychoactive and non-addictive ingredient, cannabidiol (CBD), could help prevent relapses for recovering drug addicts and alcoholics. This preclinical study’s findings provide further evidence about the possible medical benefits of non-psychoactive cannabinoids, and howRead

Cannabinoid Receptors and the Endocannabinoid System: What Is it and What Does it Do?

Endocannabinoid System

The endocannabinoid system consists of endogenous cannabinoids (endocannabinoids), cannabinoid receptors and the synthetic and degrading enzymes responsible for synthesis and degradation of endocannabinoids. Endocannabinoids are so named because they were first identified as activating the same receptors as cannabinoids, the primary psychoactive components of cannabis. Published in Journal of Neuroendocrinology 20Read

Two JAMA Studies with Podcast: Legal Cannabis Reduces Opioid Prescribing

Legal Cannabis

Recently the Journal of the American Medical Association (JAMA) published two studies and commentary on the relationship between legal cannabis use and opioid prescribing rates and patterns. We provide an 11-minute podcast from the authors and the study abstract summaries below. One study examines state implementation of medical and adult-useRead

Could Cannabidiol Be the Answer to Treatment-resistant Epilepsy & Lennox-Gastaut Syndrome?

The level of frustration and hopelessness is high among one-third of epilepsy cases that are resistant to medication. A just-released study in Lancet, outlines how a pharmaceutical formulation of cannabidiol (20 mg/kg daily), alongside other anti-epilepsy treatments, reduced the number of drop seizures – seizures which involve sudden falls due

Read more

Effectiveness of Medical Cannabis for Parkinson’s Disease

Medical Cannabis for Parkinson's
Current treatments of Parkinson disease (PD) and parkinsonism still provide suboptimal effects, especially regarding the patients’ quality of life. This has led to the search for alternative and often unconventional therapies, such as medical cannabis for Parkinson’s Disease (PD). The use of medical cannabis (MC) is controversial. Support for its

Read more

Are your Patients Asking about Cannabis?

As more states are considering legalizing medicinal and recreational marijuana, physicians are increasingly caught by surprise when patients ask about its safety and efficacy. Physicians cite a lack of knowledge about dosing guidelines and a clear understanding of the active ingredients in a recently published JAMA article, Medical Marijuana Is

Read more

JOIN OUR MAILING LIST

Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.